Change over period: —
NSE · AAREYDRUGS
AAREYDRUGS
-6.4% from the 52-week high · +112.3% above the low
Aarey Drugs & Pharmaceuticals Ltd. engages in the trade and manufacture of pharmaceutical ingredients, drug intermediates, specialty chemicals, industrial solvents, and chemicals. The company is headquartered in Mumbai, Maharashtra. The firm is also engaged in the trading of industrial solvents and chemicals. The firm is manufacturing intermediates, which include Mono Methyl Urea, Die Methyl Urea, Ortho Para Nitro Anisole, 2 Bromomethyl 1,3 Dioxalane and Uracile. The Company’s API includes Metformin Hydrochloric Acid (HCL), Mefenamic Acid and Doxophylline. The firm's chemical and solvents include aromatics chemicals, chemical acid, chloralkaline, industrial alcohols, industrial ketones, glycols and glycol ethers, fiber intermediates, industrial amines, acetates and esters, industrial oleochemicals, chlorinated solvents, industrial intermediates, industrial olefines, industrial phosphates, industrial fertilizers, industrial monomers and industrial chemicals.
The short version. Promoter holding was 41.45% in Sep 2026, down 3.35 points over 8 quarters.
1 · The price
How has the stock traded?
AAREYDRUGS trades 6.4% below its 52-week high and 112.3% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Down 3.35 pts over 8 quarters.
Up 1.93 pts over 8 quarters.
Up 1.44 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 44.8 | 44.8 | 44.8 | 44.8 | 39.06 | 37.71 | 37.71 | 41.45 | -3.35 |
| FII | 2.34 | 2.34 | 1.97 | 1.13 | 3.86 | 4.18 | 4.8 | 4.27 | +1.93 |
| DII | 0 | 0 | 0 | 0 | 0 | 1.62 | 1.62 | 1.44 | +1.44 |
| Public | 52.86 | 52.86 | 53.23 | 54.07 | 57.09 | 56.49 | 55.86 | 52.83 | -0.03 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for AAREYDRUGS are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about AAREYDRUGS
What is the AAREYDRUGS share price?
AAREYDRUGS (AAREYDRUGS) last closed at ₹110.34, up 2.4% on the day. Its 52-week range is ₹50.75 to ₹115.15.
What is the market cap of AAREYDRUGS?
AAREYDRUGS has a market capitalisation of about ₹306 crore. Its price-to-earnings ratio is 83.2.
How are AAREYDRUGS's latest results?
Promoter holding was 41.45% in Sep 2026, down 3.35 points over 8 quarters.
Who owns AAREYDRUGS?
As of Sep 2026, shareholding was: Promoter 41.45%, FII 4.27%, DII 1.44%, Public 52.83%.
How many mutual funds hold AAREYDRUGS?
0 mutual fund schemes held AAREYDRUGS in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 13 Dec 2018 · Interim Dividend - Rs. 0.1
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.